Single dose pharmacokinetics of carbamazepine-10,11-epoxide in patients on lamotrigine monotherapy
- 31 December 1994
- journal article
- Published by Elsevier in Epilepsy Research
- Vol. 19 (3), 245-248
- https://doi.org/10.1016/0920-1211(94)90068-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Lamotrigine Clinical PharmacokineticsClinical Pharmacokinetics, 1993
- LamotrigineDrugs, 1993
- A Liquid Chromatographic Assay Using a High-Speed Column for the Determination of Lamotrigine, a New Antiepileptic Drug, in Human PlasmaTherapeutic Drug Monitoring, 1992
- Impairment of carbamazepine‐10, 11‐epoxide elimination by valnoctamide, a valpromide isomer, in healthy subjects.British Journal of Clinical Pharmacology, 1992
- Lamotrigine-induced carbamazepine toxicity: an interaction with carbamazepine-10,11 -epoxideEpilepsy Research, 1992
- Lamotrigine: Preliminary clinical observations on pharmacokinetics and interactions with traditional antiepileptic drugsJournal of Epilepsy, 1992
- Interaction of Carbamazepine‐10,11‐Epoxide, an Active Metabolite of Carbamazepine, with Valproate: A Pharmacokinetic StudyEpilepsia, 1990
- Clinically Relevant Anti-Epileptic Drug InteractionsJournal of International Medical Research, 1990
- Effect of valpromide on the pharmacokinetics of carbamazepine‐10, 11‐ epoxide.British Journal of Clinical Pharmacology, 1988
- Simultaneous HPLC Determination of Oxcarbazepine, Carbamazepine and Their Metabolites in SerumJournal of Liquid Chromatography, 1984